Upset over the Devyani Khobragade episode, India on Wednesday raised with the United States its concerns over "trafficking" visas issued to family members of Sangita Richard, the absconding maid of......
In the second of a three-part series, Ranbaxy whistleblower Dinesh Thakur tells Aziz Haniffa that a formal Congress hearing on spurious drugs from India is being sought. Part I: War on......
Ranbaxy has denied sabotage at its Toansa (Punjab) factory, which makes active pharmaceutical ingredients, by workers offered voluntary retirement had led to a ban by the US Food and Drug......
In this final part of the three-part series on America's war on substandard Indian generic drugs, Aziz Haniffa speaks about US doctors' contempt for drugs exported from India and the ineptitude of......
India on Monday raised serious concerns over the USFDA's audit inspections of Indian pharma companies and 'disproportionate penalties' in some instances and said it would submit a discussion......
The concerns surrounding drug manufacturing practices in India appear to have reached foreign shores, beyond the international regulators’ domain. Ranbaxy whistle-blower Dinesh Thakur,......